United Therapeutic
(UTHR)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2019 | 12-2018 | 12-2017 | 12-2016 | 12-2015 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 738,400 | 669,200 | 705,100 | 1,023,000 | 831,800 |
| Marketable Securities | 747,500 | 746,700 | 222,300 | 27,800 | 122,000 |
| Receivables | 151,400 | 175,700 | 297,100 | 214,500 | 192,800 |
| Inventories | 93,400 | 101,000 | 107,900 | 100,000 | 81,300 |
| Other current assets | 133,800 | 75,400 | 115,500 | 59,500 | 47,400 |
| TOTAL | $1,864,500 | $1,768,000 | $1,447,900 | $1,424,800 | $1,275,300 |
| Non-Current Assets | |||||
| PPE Net | 738,500 | 699,700 | 545,700 | 489,300 | 495,800 |
| Investments And Advances | 767,500 | 442,600 | 502,700 | 2,300 | 38,000 |
| Other Non-Current Assets | 542,900 | 490,700 | 383,100 | 409,200 | 375,300 |
| TOTAL | $2,048,900 | $1,633,000 | $1,431,500 | $900,800 | $909,100 |
| Total Assets | $3,913,400 | $3,401,000 | $2,879,400 | $2,325,600 | $2,184,400 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 250,000 | 0 | N/A | N/A | N/A |
| Accounts payable and accrued liabilities | 148,400 | 166,100 | 171,100 | 104,200 | 103,400 |
| Other current liabilities | 64,600 | 110,500 | 273,600 | 228,300 | 337,300 |
| TOTAL | $463,000 | $276,600 | $444,700 | $332,500 | $440,700 |
| Non-Current Liabilities | |||||
| Long Term Debt | 600,000 | 250,000 | 250,000 | N/A | N/A |
| Other Non-Current Liabilities | 70,000 | 85,800 | 82,900 | 141,800 | 155,100 |
| TOTAL | $670,000 | $335,800 | $332,900 | $141,800 | $155,100 |
| Total Liabilities | $1,133,000 | $612,400 | $777,600 | $474,300 | $595,800 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 43,885 | 43,722 | 43,240 | 44,962 | 45,353 |
| Common Shares | 700 | 700 | 700 | 700 | 700 |
| Retained earnings | 3,325,200 | 3,434,800 | 2,845,600 | 2,433,500 | 1,719,800 |
| Other shareholders' equity | -14,400 | -8,100 | -19,800 | -16,400 | -20,500 |
| TOTAL | $2,780,400 | $2,788,600 | $2,101,800 | $1,851,300 | $1,588,600 |
| Total Liabilities And Equity | $3,913,400 | $3,401,000 | $2,879,400 | $2,325,600 | $2,184,400 |